Average Co-Inventor Count = 4.00
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (13 from 135 patents)
2. Ortho-mcneil Pharmaceutical Corp. (3 from 363 patents)
3. Zacharon Pharmaceuticals, Inc. (2 from 2 patents)
4. Tega Therapeutics, Inc. (1 from 1 patent)
19 patents:
1. 11549000 - Cellular glycosaminoglycan compositions and methods of making and using
2. 10793894 - Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
3. 10683530 - Detection of oligosaccharides
4. 10677786 - Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
5. 10260084 - Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
6. 9915649 - Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
7. 9796999 - Detection of oligosaccharides
8. 9677116 - Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
9. 9340822 - Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
10. 9222120 - Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
11. 9029530 - Detection of oligosaccharides
12. 8809009 - Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
13. 8771974 - Methods of determining the presence and/or amount of a biomarker to determine the presence, identity, and/or severity of a lysosomal storage or neurological disorder
14. 8592140 - Detection of oligosaccharides
15. 8232073 - Quantification of non-reducing end glycan residual compounds